• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom

The 5 most-read Drug Delivery Business News stories of 2024

December 23, 2024 By Sean Whooley

Tandem Diabetes Mobi insulin patch pump worn on hiker's leg drug delivery

There has been no shortage of news across the diabetes and drug delivery markets over the course of 2024. At Drug Delivery Business News, we’ve tried to cover it all. From product launches to major regulatory nods — with significant partnerships and integrations in between — diabetes technology particularly dominated the news over the last 12 […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, Dexcom, Medtronic, Roche, Tandem Diabetes Care

Oura raises $200M from investors including Dexcom

December 19, 2024 By Sean Whooley

Dexcom Stelo Oura (1)

Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health monitoring partnership between the continuous glucose monitor (CGM) maker and Oura, the maker of smart ring technology. Fidelity Management & Research Co. also contributed to the financing. San Francisco–based Oura says the financing round […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Patient Monitoring, Technology Tagged With: Dexcom, Oura

Dexcom launches generative AI platform for glucose biosensing

December 17, 2024 By Sean Whooley

Dexcom Stelo worn by pickleball player

Dexcom (Nasdaq:DXCM) announced today that it launched a proprietary generative AI platform integrated with its glucose biosensing technology. San Diego-based Dexcom says this makes it the first continuous glucose monitor (CGM) manufacturer to integrate GenAI into this technology. The new platform analyzes individual health data patterns. It could reveal a direct association between lifestyle choices […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom

European court rules in favor of Abbott in Dexcom CGM patent spat

December 12, 2024 By Sean Whooley

Dexcom G7 Abbott FreeStyle Libre 2 CGM

The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom (Nasdaq:DXCM). Abbott and Dexcom are two leaders in the continuous glucose monitoring (CGM) space. They offer market-leading platforms, with Abbott’s FreeStyle Libre 3 and Dexcom’s G7 representing their latest-generation technologies. Dexcom requested that the court find infringement […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Legal News, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: abbott, Dexcom

Tandem makes t:slim X2 insulin pump available with Dexcom G7 in Canada

December 10, 2024 By Sean Whooley

Tandem Diabetes Care t-slim X2 Dexcom G7

Tandem Diabetes Care (Nasdaq:TNDM) announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with Dexcom (Nasdaq:DXCM) CGMs. Following authorization from Health Canada, in-warranty pump users can access full compatibility with the G7 and G6 CGMs. This makes t:slim X2 the first and only pump integrated with both continuous glucose […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Dexcom, Tandem Diabetes Care

Dexcom invests $75M in Oura as companies strike health monitoring partnership

November 19, 2024 By Sean Whooley

Dexcom Stelo Oura (1)

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology. The partnership aims to help people improve their metabolic health by integrating Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from the Oura Ring. Combining glucose data with biometrics can deliver […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Oura

The biggest diabetes tech stories of the year so far

November 14, 2024 By Sean Whooley

ADA 2024 Product Images Dexcom Abbott Senseonics Ascensia Insulet Tandem Medtronic Sequel

On World Diabetes Day, it’s worth taking a look back at the last 10.5 months in the diabetes technology space. The date, which marks the birth date of the inventor of insulin, brings out all sorts of initiatives from various companies involved in innovating these technologies (read about those HERE). Those companies have contributed to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pain Management, Technology Tagged With: abbott, Dexcom, embecta, Insulet, Medtronic, National Diabetes Awareness Month 2024, Roche, Roche Diabetes Care, Senseonics, Sequel Med Tech, Tandem Diabetes Care, World Diabetes Day 2024

What diabetes tech companies are doing on World Diabetes Day 2024

November 14, 2024 By Sean Whooley

World Diabetes day

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after year. This date serves as a time to recognize these innovations as it marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. The […]

Filed Under: Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, Ascensia Diabetes Care, Dexcom, embecta, Fresenius Medical Care, Insulet, Medtronic, National Diabetes Awareness Month 2024, World Diabetes Day 2024

Dexcom highlights diabetes awareness with global star power

November 14, 2024 By Sean Whooley

Nick Jonas Dexcom CGM World Diabetes Day WDD (1)

Dexcom (Nasdaq:DXCM) today announced survey data outlining the importance of raising awareness of diabetes. The company surveyed 2,250 individuals all over the world over 18 with type 1 or type 2 diabetes. Nearly 70% of people with diabetes say they didn’t know where to begin their health journey when first diagnosed. Nearly half say diabetes […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, National Diabetes Awareness Month 2024, World Diabetes Day 2024

Dexcom submits 15-day CGM to FDA, beats Street in Q3

October 25, 2024 By Sean Whooley

Dexcom G7 iPhone (1)

Dexcom (Nasdaq:DXCM) announced that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA. G7, the company’s latest-generation continuous glucose monitor (CGM), presently has approval for a 10-day wear time. Shares of DXCM were up slightly at the opening of trading today. Yesterday evening, Dexcom also reported third-quarter results […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Dexcom

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 17
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS